C

Cellectis SA
D

CLLS

1.58000
USD
0.00
(0.00%)
Market Closed
Volume
762
EPS
-1
Div Yield
-
P/E
-1
Market Cap
158,148,319
OverviewSignalsIdeasNews
Related Instruments
    A
    ALLO
    0.03500
    (1.91%)
    1.87000 USD
    B
    BEAM
    2.190
    (8.16%)
    29.020 USD
    B
    BLUE
    -0.69000
    (-7.52%)
    8.49000 USD
    C
    CRSP
    0.360
    (0.89%)
    40.720 USD
    E
    EDIT
    -0.01000
    (-0.75%)
    1.32000 USD
    F
    FATE
    0.04000
    (2.42%)
    1.69000 USD
    GILD
    GILD
    1.460
    (1.60%)
    92.570 USD
    N
    NTLA
    0.120
    (0.99%)
    12.190 USD
    VRTX
    VRTX
    0.58
    (0.15%)
    397.15 USD
    More
News

Title: Cellectis SA

Sector: Healthcare
Industry: Biotechnology
Cellectis SA is a clinical stage biotechnological company, employing the core proprietary technologies to develop products based on gene-editing, with a portfolio of allogeneic Chimeric Antigen Receptor T-cells, or UCART, product candidates in the field of immuno-oncology and gene-edited hematopoietic stem and progenitor cells, or HSPC, product candidates in other therapeutic indications.